17 alpha-hydroxyprogesterone caproate and Thromboembolism, Venous

17 alpha-hydroxyprogesterone caproate has been researched along with Thromboembolism, Venous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ananth, CV; D'Alton, ME; Friedman, AM; Gomez, D; Gyamfi-Bannerman, C; Huang, Y; Schuster, M; Wright, JD	1

Other Studies

1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Thromboembolism, Venous

Article	Year
17-alpha hydroxyprogesterone caproate and risk for venous thromboembolism during pregnancy. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2022, Volume: 35, Issue:25 Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Infant, Newborn; Pregnancy; Premature Birth; Progestins; Retrospective Studies; Venous Thromboembolism	2022

Article

Year

17-alpha hydroxyprogesterone caproate and risk for venous thromboembolism during pregnancy.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2022, Volume: 35, Issue:25

Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Infant, Newborn; Pregnancy; Premature Birth; Progestins; Retrospective Studies; Venous Thromboembolism

2022